Segall Bryant & Hamill LLC Reduces Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

Segall Bryant & Hamill LLC cut its holdings in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 1.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,753,806 shares of the company's stock after selling 50,175 shares during the period. AdaptHealth makes up approximately 0.8% of Segall Bryant & Hamill LLC's portfolio, making the stock its 11th biggest position. Segall Bryant & Hamill LLC owned approximately 3.52% of AdaptHealth worth $51,531,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. GAMMA Investing LLC increased its holdings in AdaptHealth by 175.2% during the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after purchasing an additional 4,758 shares in the last quarter. Guggenheim Capital LLC grew its holdings in shares of AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after acquiring an additional 1,525 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of AdaptHealth in the fourth quarter valued at approximately $169,000. Humankind Investments LLC grew its holdings in shares of AdaptHealth by 18.3% in the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock valued at $171,000 after acquiring an additional 2,776 shares in the last quarter. Finally, Proficio Capital Partners LLC bought a new position in shares of AdaptHealth in the fourth quarter valued at approximately $181,000. 82.67% of the stock is owned by institutional investors.

Analyst Ratings Changes

AHCO has been the subject of several recent analyst reports. Royal Bank Of Canada reduced their target price on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Truist Financial reduced their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $13.40.

AdaptHealth Stock Performance

NASDAQ AHCO traded up $0.02 on Friday, hitting $9.22. 1,028,034 shares of the stock traded hands, compared to its average volume of 1,334,057. The business's fifty day moving average is $8.99 and its two-hundred day moving average is $9.40. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.90. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of 16.18, a PEG ratio of 1.07 and a beta of 1.63. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.07 and a current ratio of 1.29.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.